Cibc Asset Management Inc Maravai Lifesciences Holdings, Inc. Transaction History

Cibc Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$20.6 - $30.37 $824 - $1,214	-40 Reduced 0.4%	9,982 $255,000
Q2 2022 Aug 09, 2022	SELL	$26.05 - $37.48 $18,599 - $26,760	-714 Reduced 6.65%	10,022 $285,000
Q1 2022 May 06, 2022	SELL	$24.46 - $40.92 $3,620 - $6,056	-148 Reduced 1.36%	10,736 $379,000
Q4 2021 Feb 08, 2022	BUY	$35.0 - $45.94 $4,025 - $5,283	115 Added 1.07%	10,884 $456,000
Q3 2021 Nov 09, 2021	SELL	$36.8 - $60.62 $143,225 - $235,933	-3,892 Reduced 26.55%	10,769 $529,000
Q2 2021 Aug 16, 2021	SELL	$32.46 - $45.0 $132,664 - $183,915	-4,087 Reduced 21.8%	14,661 $612,000
Q1 2021 May 14, 2021	BUY	$25.8 - $38.49 $271,880 - $405,607	10,538 Added 128.36%	18,748 $668,000
Q4 2020 Feb 03, 2021	BUY	$24.5 - $30.86 $201,145 - $253,360	8,210 New	8,210 $230,000

235

141M

223K

19.4K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $746M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.